Psychological stress as a measure for treatment response prediction in idiopathic sudden hearing loss

- Responder and non-responder are differentiated by various psychological measures.
- Depressive stress response is the strongest predictor of treatment outcome in ISSNHL.
- The duration of hearing loss is a significant predictor of treatment outcome in ISSNHL.
- Psychiatric approach is potentially useful to enhance therapeutic outcomes.

ObjectiveEarly prediction of therapeutic outcomes could reduce exposure to ineffective treatments and optimize clinical outcomes. However, none of the known otologic predictors is amenable to therapeutic intervention for idiopathic sudden sensorineural hearing loss (ISSNHL). The aims of this study were to investigate psychological stress as a potential predictor to discriminate outcomes in ISSNHL.MethodsVarious psychological measures were conducted including structured interview assessment tools in patients with recently diagnosed ISSNHL before initiating treatment. Using logistic regression analysis, we identified the predictors of treatment response and estimated the probability of treatment response in 50 ISSNHL patients who participated in a clinical trial.ResultsTreatment non-responders were significantly differentiated from responders by various psychological problems. The depression subscore of Modified form of Stress Response Inventory (SRI-MF) (p = 0.007) and duration of hearing loss (p = 0.045) significantly predicted treatment response after controlling other clinical correlates. The same predictors were identified from different treatment response measured using Siegel's criteria. The most discriminative measure for treatment response was SRI-MF depression score with an overall classification accuracy of 73%.ConclusionsWe found depressive stress response to be the strong predictor of treatment response in patients with ISSNHL. Our results highlight the potential use of the psychiatric approach as a tool for enhancing therapeutic outcomes. Future stress intervention studies with larger number of ISSNHL patients are needed.